- Home
- LITB vs PYPD Comparison
LITB vs PYPD Comparison
Compare LITB & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- PYPD
- Stock Information
- Founded
- LITB 2007
- PYPD 2008
- Country
- LITB Singapore
- PYPD Israel
- Employees
- LITB N/A
- PYPD N/A
- Industry
- LITB Catalog/Specialty Distribution
- PYPD Medical/Dental Instruments
- Sector
- LITB Consumer Discretionary
- PYPD Health Care
- Exchange
- LITB Nasdaq
- PYPD Nasdaq
- Market Cap
- LITB 20.5M
- PYPD 35.3M
- IPO Year
- LITB N/A
- PYPD 2020
- Fundamental
- Price
- LITB $1.16
- PYPD $3.49
- Analyst Decision
- LITB
- PYPD Strong Buy
- Analyst Count
- LITB 0
- PYPD 5
- Target Price
- LITB N/A
- PYPD $11.40
- AVG Volume (30 Days)
- LITB 10.6K
- PYPD 1.4M
- Earning Date
- LITB 08-01-2025
- PYPD 08-13-2025
- Dividend Yield
- LITB N/A
- PYPD N/A
- EPS Growth
- LITB N/A
- PYPD N/A
- EPS
- LITB 0.08
- PYPD N/A
- Revenue
- LITB $231,136,000.00
- PYPD N/A
- Revenue This Year
- LITB N/A
- PYPD N/A
- Revenue Next Year
- LITB N/A
- PYPD N/A
- P/E Ratio
- LITB $15.16
- PYPD N/A
- Revenue Growth
- LITB N/A
- PYPD N/A
- 52 Week Low
- LITB $0.91
- PYPD $2.30
- 52 Week High
- LITB $5.70
- PYPD $4.42
- Technical
- Relative Strength Index (RSI)
- LITB 45.65
- PYPD 55.68
- Support Level
- LITB $1.11
- PYPD $3.42
- Resistance Level
- LITB $1.25
- PYPD $3.62
- Average True Range (ATR)
- LITB 0.09
- PYPD 0.19
- MACD
- LITB 0.01
- PYPD -0.02
- Stochastic Oscillator
- LITB 34.00
- PYPD 58.92
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.